Holding patients hostage: Why drug prices in the US are higher than ever

Rising drug costs are an increasingly important priority in the US. Americans spend more on healthcare than any other country in the world for worse outcomes. While politicians have attributed rising costs largely in part to relying on offshore pharmaceutical manufacturing, the full picture is far more complex.

To help reduce the estimated $4.8 trillion spent annually on health expenditure, companies like SHARx are trying to close the gap by sourcing prescriptions outside of the insurance system.